10 November 2025 in BMJ Paediatrics Open
Objective: Differentiating between functional and organic gastrointestinal disorders in infants and young children remains a diagnostic challenge. Faecal calprotectin (FC) has emerged as a non-invasive biomarker that can help to exclude organic pathology. This study aimed to establish age-specific reference ranges for FC in healthy Hungarian children aged 0–36 months, providing a practical tool for paediatric clinical decision-making. Methods: A total of 282 stool samples were obtained from 245 healthy children (142 boys, 103 girls). Eligibility was determined using strict inclusion criteria based on parental interviews and questionnaires. FC concentrations were measured with a single-test ELISA assay (Orgentec Sebia Diagnostika). Data analysis employed Random Forest Regression and non-parametric statistical methods, following the Clinical and Laboratory Standards Institute EP28-A3c guideline. Results: Median FC concentrations by age group were: 0–4 months, 181 µg/g (IQR 92.5–289.6); 4–12 months, 40.6 µg/g (IQR 14.2–100.3); and 12–36 months, 24.7 µg/g (IQR 4.62–59.27). FC levels peaked in the youngest age group (0–4 months) and declined steadily thereafter, showing a consistent downward shift in both median and upper percentile values with increasing age. No significant associations were found between FC and gender, birth weight, mode of delivery or type of nutrition. Conclusions: This study provides age-specific reference values for FC in Hungarian children under 3 years of age. These results support the clinical use of FC testing to help exclude organic gastrointestinal disease, while emphasising the importance of appropriate test indication. The assay used proved to be reliable, minimally invasive, cost-effective and well suited for routine paediatric practice.
12 January 2026 in International Journal of Medical Microbiology
Our study determined the prevalence, types of RSV, and sequence variability of the G and F genes in Hungary between 2017 and 2023. During the study, 1828 respiratory samples were collected from hospitalised pediatric patients. We confirmed the presence of RSV A in 12.74 %, RSV B in 13.85 %, and their simultaneous presence in 0.27 %. The highest RSV positivity was observed in the 2018-2019 season, while the lowest was in the 2017-2018 season. Following the SARS-CoV-2 pandemic, the RSV season has an earlier onset and longer duration than it did previously; however, an earlier onset was already detected in 2018. All RSV A isolates are classified into the A.D., while RSV B into the B.D. clades. The entire ectodomain of G protein showed a high sequence diversity, higher than in the case of B.D. strains. Mutations at position 276, adjacent to the palivizumab binding site of the F protein, could be detected. At the same time, neither K272E/N nor any other mutation is present in the palivizumab binding region in our strains. Several mutations in the nirsevimab binding region could be detected in our strains; however, none of these mutations, which would affect nirsevimab activity, were found in our isolates.